Press release archive | GSK
GSK is pleased to rank 2nd in the Access to Medicine Index (ATMI) in its ninth wave. Full data to be presented at 2024 American Society of Hematology Annual Meeting in December. New data shows potential for sequential therapy of bepirovirsen after daplusiran/tomligisiran to further increase functional cure rates.
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
Press releases | GSK US
GSK announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the safety of AREXVY and SHINGRIX. GSK confirmed it has reached two …
GSK announces cap of $35 per month on U.S. patient out-of …
GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines,* the most prescribed portfolio of inhalers in the U.S. GSK is taking this action as part of its longstanding commitment to improving access to respiratory medici...
GlaxoSmithKline News | GSK News - NewsNow
NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications.
GSK plc (GSK) Stock Price, News, Quote & History - Yahoo Finance
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.
GSK lifts annual forecasts again, powered by strong vaccine launch
Nov 1 (Reuters) - GSK (GSK.L) raised its full-year profit and sales forecasts for a second time on Wednesday, following the strong launch of its respiratory syncytial virus (RSV) vaccine in the...
US FDA approves GSK’s AREXVY, the world’s first respiratory …
May 3, 2023 · AREXVY is the first approved RSV vaccine for older adults, expanding GSK’s industry-leading vaccine portfolio, which protects millions of people from infectious diseases each year. Our focus now is to ensure eligible older adults in the US can access the vaccine as quickly as possible and to progress regulatory review in other countries.”
GlaxoSmithKline | AP News
Dec 19, 2018 · A research scientist from California pleaded guilty Friday in Philadelphia federal court to receiving trade secrets on anticancer research smuggled from pharmaceutical giant GlaxoSmithKline to bolster a fledgling but potential rival startup in China.
GSK Stock Quote Price and Forecast | CNN
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates …